Financial Avengers’s Medtronic MDT Stock Holding History

Financial Avengers’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250	Closed	-$30K	–	157
2021 Q1	$30K	Hold	250	–	–	0.02%	79
2020 Q4	$29K	Buy	+250	New	+$27.5K	0.02%	74

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Avengers's MDT Position: Q2 2021 in Review

Financial Avengers sold out of Medtronic (MDT) in Q2 2021, closing a stake of 250 shares — an estimated $30K sold.

Financial Avengers first reported a position in MDT in Q4 2020 and held it in 2 quarters. The position peaked at $30K in Q1 2021. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

Financial Avengers reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
Financial Avengers sold 250 Medtronic shares in Q2 2021, an estimated $30K.
Financial Avengers first reported a position in Medtronic in Q4 2020 and held it in 2 quarters.
Financial Avengers's Medtronic position peaked at $30K in Q1 2021.
2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Financial Avengers's 13F filing for Q2 2021, filed 13 Aug 2021.